31.2. Analysis.
Comparison 31 NRD‐101 (Suvenyl) versus placebo (saline plus oral placebo), Outcome 2 Lequesne Index (0‐100 modified scale) change between baseline and 45 to 52 weeks post‐injection.
Comparison 31 NRD‐101 (Suvenyl) versus placebo (saline plus oral placebo), Outcome 2 Lequesne Index (0‐100 modified scale) change between baseline and 45 to 52 weeks post‐injection.